BAAM
Baker Avenue Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.34M | Buy |
23,034
+2,704
| +13% | +$1.1M | 0.27% | 81 |
|
|
2025
Q1 | $10.1M | Buy |
20,330
+429
| +2% | +$213K | 0.32% | 70 |
|
|
2024
Q4 | $10.4M | Sell |
19,901
-1,039
| -5% | -$541K | 0.32% | 66 |
|
|
2024
Q3 | $13M | Buy |
20,940
+7,476
| +56% | +$4.62M | 0.41% | 59 |
|
|
2024
Q2 | $7.45M | Buy |
13,464
+278
| +2% | +$154K | 0.25% | 75 |
|
|
2024
Q1 | $7.66M | Buy |
13,186
+778
| +6% | +$452K | 0.3% | 72 |
|
|
2023
Q4 | $6.59M | Buy |
12,408
+423
| +4% | +$225K | 0.29% | 79 |
|
|
2023
Q3 | $6.07M | Buy |
11,985
+130
| +1% | +$65.8K | 0.3% | 76 |
|
|
2023
Q2 | $6.19M | Sell |
11,855
-496
| -4% | -$259K | 0.31% | 70 |
|
|
2023
Q1 | $7.12M | Sell |
12,351
-413
| -3% | -$238K | 0.38% | 63 |
|
|
2022
Q4 | $7.03M | Sell |
12,764
-81
| -0.6% | -$44.6K | 0.42% | 60 |
|
|
2022
Q3 | $6.52M | Sell |
12,845
-182
| -1% | -$92.3K | 0.41% | 64 |
|
|
2022
Q2 | $7.08M | Sell |
13,027
-107
| -0.8% | -$58.1K | 0.47% | 58 |
|
|
2022
Q1 | $7.76M | Buy |
13,134
+30
| +0.2% | +$17.7K | 0.4% | 64 |
|
|
2021
Q4 | $8.74M | Buy |
13,104
+554
| +4% | +$370K | 0.44% | 61 |
|
|
2021
Q3 | $7.17M | Buy |
12,550
+346
| +3% | +$198K | 0.41% | 64 |
|
|
2021
Q2 | $6.16M | Buy |
12,204
+577
| +5% | +$291K | 0.35% | 72 |
|
|
2021
Q1 | $5.31M | Buy |
+11,627
| New | +$5.31M | 0.33% | 68 |
|